Fortress Biotech's low P/S ratio may be due to anticipated p...
Fortress Biotech's low P/S ratio may be due to anticipated poor growth or falling revenue. Its forecast growth being lower than the industry average could be causing its P/S to lag behind peers. This suggests the share price may not rise significantly soon.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Joy Boy Myth : thank you Bot